Thryvv : ratio page

Alkem Laboratories

Overview Articles Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
32.89
41.27
26.28
20.91
24.70
PCE(x)
27.98
30.84
21.79
17.51
19.86
Price/Book(x)
5.74
4.49
5.01
4.49
4.52
Yield(%)
0.81
1.47
0.94
1.08
1.07
EV/Net Sales(x)
4.63
3.39
4.07
3.71
3.40
EV/Core EBITDA(x)
22.96
21.53
19.52
15.10
17.98
EV/EBIT(x)
27.48
27.84
22.80
17.28
21.41
EV/CE(x)
5.09
3.80
3.39
3.16
3.65
MCap / Sales
4.66
3.50
4.07
3.74
3.34
Growth Ratio:
Net Sales Growth(%)
9.21
9.08
19.96
6.24
13.42
Core EBITDA Growth(%)
40.03
-17.60
1.84
37.90
31.20
EBIT Growth(%)
51.23
-25.55
-0.23
43.49
31.27
PAT Growth(%)
79.92
-40.08
3.87
40.76
48.56
EPS Growth(%)
82.47
-40.19
3.82
40.63
48.20
Financial Stability Ratios:
Total Debt/Equity(x)
0.12
0.14
0.30
0.23
0.26
Current Ratio(x)
2.61
2.32
1.76
1.92
1.69
Quick Ratio(x)
1.94
1.62
1.13
1.28
1.13
Interest Cover(x)
19.00
13.15
36.22
32.26
20.36
Total Debt/Mcap(x)
0.02
0.03
0.06
0.05
0.06
Operational & Financial Ratios:
Earnings Per Share (Rs)
150.21
82.32
137.65
132.58
94.28
CEPS(Rs)
176.56
110.18
165.98
158.29
117.28
DPS(Rs)
40.00
50.00
34.00
30.00
25.00
Book NAV/Share(Rs)
860.94
756.56
722.48
616.95
515.21
Tax Rate(%)
10.46
22.84
8.89
12.18
8.77
Margin Ratios:
Core EBITDA Margin(%)
11.58
8.97
13.44
14.82
11.89
EBIT Margin(%)
11.02
7.87
12.42
14.50
10.69
Pre Tax Margin(%)
10.44
7.27
12.07
14.05
10.16
PAT Margin (%)
9.35
5.61
11.00
12.34
9.27
Cash Profit Margin (%)
10.89
7.34
12.99
14.43
11.31
Performance Ratios:
ROA(%)
13.66
7.99
14.50
16.66
13.92
ROE(%)
18.74
11.39
20.99
23.91
19.82
ROCE(%)
19.52
13.09
18.69
22.56
18.71
Asset Turnover(x)
1.46
1.42
1.32
1.35
1.50
Sales/Fixed Asset(x)
4.51
4.36
3.86
3.58
3.74
Working Capital/Sales(x)
3.02
3.66
4.21
3.95
5.53
Efficiency Ratios:
Fixed Capital/Sales(x)
0.22
0.23
0.26
0.28
0.27
Receivable days
41.28
40.86
41.72
45.33
42.66
Inventory Days
49.60
57.10
63.54
57.51
48.86
Payable days
122.87
97.40
114.79
118.18
118.18